Directeur de département, Faculté de médecine et des sciences de la santé
FMSS Dép. de biochimie et de génomique fonction.
(2004) Post-doctorate (Postdoctorate Neurosciences). McGill University.
(2002) Post-doctorate (Postdoctorate Cell Biology). University of Geneva.
(2000) Post-doctorate (Postdoctorate Biochemistry and Molecular Biology). Monash University.
(1996) Doctorate (Doctorate Life Sciences). Université Victor Ségalen Bordeaux 2.
(1992) Master's non-Thesis (Master's Biological Sciences - Masters). Université Victor Ségalen Bordeaux 2.
(2017) Department Chair. Université de Sherbrooke.
Cell, Cellular Degeneration, Enzymes and Proteins, Neurodegenerative Diseases, Functional and Structural Proteomics, Nucleic Acids.
Biochemistry, Cell Biology, Molecular Biology.
Membranes Biochemistry, Mitochondria/Apoptosis, Protein database, Proteomics, Site-directed Mutagenesis.
Functional proteomics and discovery of novel proteins Pathobiological function of proteins in neuronal degeneration and cancer
Centre de recherche du CHUS
Anglais, Français, Espagnol (castillan)
Grant. (Under Review). Principal Applicant. Challenging the dogmas of monocistronic genes and pseudogenes using proteogenomics and systems biology approaches to better define the human proteome in health and diseases. Canadian Institutes of Health Research (CIHR). Project grant. 1525000 $ (2021-2026).
Grant. (Awarded). Co-applicant. UbiquitinKEKS: function of a novel ubiquitin isoform encoded by UBBP4. Canadian Institutes of Health Research (CIHR). Project. 891226 $ (2018-2023).
Research Chair. (Awarded). Principal Applicant. Canada Research Chair in Functional Proteomics and Discovery of Novel Proteins. Canadian Institutes of Health Research (CIHR). Canada Research Chair Tier1. 1400000 $ (2015-2022).
Grant. (Awarded). Co-investigator. Development of precision therapeutic vaccines against acute myeloid and lymphoid leukemias. Fonds de recherche du Québec - Santé (FRQS). Oncopole. 1500000 $ (2018-2021).
Grant. (Awarded). Principal Applicant. Cracking the FUS code in ALS: From the dual-coding gene FUS, alt-FUS engages too in the pathology. Amyotrophic Lateral Sclerosis (ALS) Society of Canada. Operating. 125000 $ (2018-2021).
Grant. (Awarded). Principal Applicant. OpenProt 2.0. Compute Canada. Resource Allocation Competition. 35573 $ (2020-2021).
Grant. (Completed). Principal Applicant. OpenProt. Compute Canada. Fast Track. 116621 $ (2019-2020).
Grant. (Completed). Principal Investigator. Function of alternative proteins in Neurodegenerative Diseases. (2014-2019).
Grant. (Completed). Principal Applicant. OpenProt. Compute Canada. Fast Track (1138 CPU). 179983 $ (2018-2019).
Grant. (Completed). Co-applicant. Precision medicine: a mass spectrometer for the discovery of new protein biomarkers. Canada Foundation for Innovation (CFI). John R. Evans Leaders Fund. 1583499 $ (2018-2019).
Grant. (Completed). Principal Applicant. OpenProt. Compute Canada. Resources for Research Groups (1224 CPU). 231140 $ (2017-2018).
Grant. (Completed). Principal Applicant. OpenProt. Compute Canada. Resources for Research Groups (1181 CPU). 195260 $ (2016-2017).
Grant. (Completed). Co-applicant. 600 MHz Solution-State NMR Upgrade for Structural Biology. Canada Foundation for Innovation (CFI). John R. Evans Leaders Fund. 891938 $ (2016).
Les informations disponibles dans la base de données Expertus sont tirées du CV commun canadien.